The latest closing stock price for Xilio Therapeutics as of November 20, 2024 is 0.94.
An investor who bought $1,000 worth of Xilio Therapeutics stock at the IPO in 2021 would have $-941 today, roughly -1 times their original investment - a -61.11% compound annual growth rate over 3 years.
The all-time high Xilio Therapeutics stock closing price was 25.11 on November 16, 2021.
The Xilio Therapeutics 52-week high stock price is 1.93, which is 105.3% above the current share price.
The Xilio Therapeutics 52-week low stock price is 0.49, which is 47.9% below the current share price.
The average Xilio Therapeutics stock price for the last 52 weeks is 0.90.
An investor who bought $1,000 worth of Xilio Therapeutics stock at the IPO in 2021 would have $-941 today, roughly -1 times their original investment - a -61.11% compound annual growth rate over 3 years.
The all-time high Xilio Therapeutics stock closing price was 25.11 on November 16, 2021.
The Xilio Therapeutics 52-week high stock price is 1.93, which is 105.3% above the current share price.
The Xilio Therapeutics 52-week low stock price is 0.49, which is 47.9% below the current share price.
The average Xilio Therapeutics stock price for the last 52 weeks is 0.90.